Cuba - Active pharmaceutical ingredients (API)
This is a business opportunity from an overseas buyer. Pitch for the business and explain how your company meets their requirements.
Details
- Opportunity closing date
- 28 February 2020
- Opportunity publication date
- 06 December 2019
- Opportunity type
-
Public Sector
- Industry
- Pharmaceuticals and biotechnology, Chemicals, Healthcare services
- Enquiries received
- 3
- Value of contract
- to be confirmed
- Your guide to exporting
Description
You must be able to supply:
- abacavir sulfate (API)
- amiodarone hydrochloride (API)
- amlodipine besylate (API)
- ascorbic acid (API)
- chlorthalidone (API)
- ciprofloxacin hydrochloride (API)
- clonazepam (API)
- clopidogrel sulfate (API)
- corn starch 1500 pregelatinised (excipient)
- granulated ascorbic Acid CD 90 (API)
- Isopropyl alcohol (excipient)
- lactose monohydrate (excipient)
- magnesium stearate (excipient)
- methyldopa (API)
- microcrystalline cellulose MC-101 (excipient)
- microcrystalline cellulose MC-102 (excipient)
- micronized ferrous fumarate (API)
- micronized folic acid (API)
- micronized glimepiride (API)
- naproxen (API)
- tramadol hydrochloride (API)
- undecylenic acid (API)
- Opportunity closing date
- 28 February 2020
- Value of contract
- to be confirmed
- The buyer is happy to talk to
- manufacturers, wholesalers
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.